rs727505153
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The ENST00000272371.7(OTOF):c.1930G>A(p.Val644Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,612,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
ENST00000272371.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194248.3 | c.1930G>A | p.Val644Ile | missense_variant | 17/47 | ENST00000272371.7 | NP_919224.1 | |
OTOF | NM_001287489.2 | c.1930G>A | p.Val644Ile | missense_variant | 17/46 | NP_001274418.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.1930G>A | p.Val644Ile | missense_variant | 17/47 | 1 | NM_194248.3 | ENSP00000272371 | A1 | |
OTOF | ENST00000403946.7 | c.1930G>A | p.Val644Ile | missense_variant | 17/46 | 5 | ENSP00000385255 | P4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152284Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000401 AC: 1AN: 249492Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135554
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460220Hom.: 0 Cov.: 34 AF XY: 0.00000413 AC XY: 3AN XY: 726306
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152284Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74402
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 25, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Aug 12, 2021 | The Val644Ile variant in OTOF has not been previously reported in individuals with hearing loss but has been identified in 0.0015% (2/127688) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Valine (Val) at position 644 is not conserved in mammals or evolutionarily distant species and 1 mammal (Baboon) and many distant species carry an isoleucine (Ile) at this position, supporting that this change may be tolerated. Additional computational prediction tools suggest that this variant may not impact the protein. In summary, while the clinical significance of the Val644Ile variant is uncertain, these data suggest that it is more likely to be benign. ACMG/AMP Criteria applied: PM2_P, BP4. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at